Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain

被引:25
作者
Mazza, Marianna [1 ]
Mazza, Osvaldo [2 ]
Pazzaglia, Costanza [3 ,4 ]
Padua, Luca [3 ,4 ]
Mazza, Salvatore [4 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Psychiat & Psychol, Dept Neurosci, I-00136 Rome, Italy
[2] Bambino Gesu Paediat Hosp, Palidoro Rome, Italy
[3] Fdn Pro Juventute Don Carlo Gnocchi, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Clin Neurophysiol & Epilepsy Ctr, Dept Neurosci, I-00136 Rome, Italy
关键词
DOUBLE-BLIND; PRIMARY-CARE; ANTIDEPRESSANTS; PLACEBO; DEPRESSION; MANAGEMENT; TRIAL;
D O I
10.1517/14656561003730413
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Escitalopram has never been demonstrated to be useful in the treatment of chronic low back pain (CLBP), while duloxetine has demonstrated analgesic effect in chronic pain states. The aim of this trial was to examine the efficacy of escitalopram for the treatment of CLBP compared with duloxetine. Methods: A total of 85 adult patients with non-radicular CLBP entered a 13-week randomized study comparing escitalopram 20 mg with duloxetine 60 mg once daily. The primary measure was comparison of the two drugs on reduction in weekly mean 24-h average pain. Secondary measures included Clinical Global Impressions of Severity (CGI-S) and the 36-item Short-Form Health Survey (SF-36). Results: Eighty patients (n = 39 escitalopram, n = 41 duloxetine) completed the study. No significant differences existed between escitalopram and duloxetine on reduction in weekly mean 24-h average pain at end point. Both escitalopram and duloxetine demonstrated significant improvement on CGI-S and SF-36. Conclusions: Escitalopram and duloxetine demonstrated efficacy and safety in the management of CLBP, with no significant differences. Results of this study should be replicated in a larger sample of patients.</.
引用
收藏
页码:1049 / 1052
页数:4
相关论文
共 19 条
[1]   The antinociceptive effect of antidepressants - noradrenergic versus serotonergic modes of action? [J].
Aigner, M ;
Bach, M .
PAIN, 2000, 88 (02) :217-217
[2]   Epidemiological features of chronic low-back pain [J].
Andersson, GBJ .
LANCET, 1999, 354 (9178) :581-585
[3]   Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity [J].
Atkinson, JH ;
Slater, MA ;
Wahlgren, DR ;
Williams, RA ;
Zisook, S ;
Pruitt, SD ;
Epping-Jordan, JE ;
Patterson, TL ;
Grant, I ;
Abramson, I ;
Garfin, SR .
PAIN, 1999, 83 (02) :137-145
[4]   A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain [J].
Atkinson, JH ;
Slater, MA ;
Williams, RA ;
Zisook, S ;
Patterson, TL ;
Grant, I ;
Wahlgren, DR ;
Abramson, I ;
Garfin, SR .
PAIN, 1998, 76 (03) :287-296
[5]  
Delgado PL, 2004, J CLIN PSYCHIAT, V65, P16
[6]   Primary care - Low back pain [J].
Deyo, RA ;
Weinstein, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) :363-370
[7]   Core outcome measures for chronic pain clinical trials: IMMPACT recommendations [J].
Dworkin, RH ;
Turk, DC ;
Farrar, JT ;
Haythornthwaite, JA ;
Jensen, MP ;
Katz, NP ;
Kerns, RD ;
Stucki, G ;
Allen, RR ;
Bellamy, N ;
Carr, DB ;
Chandler, J ;
Cowan, P ;
Dionne, R ;
Galer, BS ;
Hertz, S ;
Jadad, AR ;
Kramer, LD ;
Manning, DC ;
Martin, S ;
McCormick, CG ;
McDermott, MP ;
McGrath, P ;
Quessy, S ;
Rappaport, BA ;
Robbins, W ;
Robinson, JP ;
Rothman, M ;
Royal, MA ;
Simon, L ;
Stauffer, JW ;
Stein, W ;
Tollett, J ;
Wernicke, J ;
Witter, J .
PAIN, 2005, 113 (1-2) :9-19
[8]  
Fava M, 2004, J CLIN PSYCHIAT, V65, P521
[9]   Evidence-based data on pain relief with antidepressants [J].
Fishbain, D .
ANNALS OF MEDICINE, 2000, 32 (05) :305-316
[10]  
GUY W., 1976, NATL I MENTAL HLTH P